Governance

This page summarises Aescia’s governance approach for clinical evaluation engagements.

Legal entity

Aescia Pty Ltd (Australia). ABN and GST registration available on public registries.

Accountability and clinical responsibility

Aescia is designed as a clinician-in-the-loop workflow support tool. Clinical decisions remain the responsibility of the treating clinical team at all times.

Clinical governance approach

For evaluation deployments, Aescia operates under:

• site-specific governance approval processes (e.g., digital health, clinical governance, and privacy review)
• a documented risk assessment for the evaluation scope
• role clarity for escalation pathways (who monitors, who responds, timeframes)

Ethics and evaluation posture

Aescia is used under clinical evaluation or research frameworks only, subject to appropriate approvals. The platform is not marketed for routine clinical deployment without governance approval.

Reporting and transparency

Evaluation reporting is agreed in advance, including endpoints, adverse events, usage metrics, and qualitative feedback. Where permitted, neutral or negative findings may be reported.

Contact for governance queries

For governance and evaluation questions, contact: Contact.